9XW2
Cryo-EM structure of PI3Kalpha E542K mutation in complex with RLY-2608
Summary for 9XW2
| Entry DOI | 10.2210/pdb9xw2/pdb |
| EMDB information | 67320 |
| Descriptor | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform, N-{(3R,6M)-3-(2-chloro-5-fluorophenyl)-6-[(4S)-5-cyano[1,2,4]triazolo[1,5-a]pyridin-6-yl]-1-oxo-2,3-dihydro-1H-isoindol-4-yl}-3-fluoro-5-(trifluoromethyl)benzamide (2 entities in total) |
| Functional Keywords | phosphoinositide 3-kinase, drug target, ligand, binding pocket, hotspot mutation, allosteric inhbitor, structural protein |
| Biological source | Homo sapiens (human) |
| Total number of polymer chains | 1 |
| Total formula weight | 128431.55 |
| Authors | |
| Primary citation | Liu, X.,Chen, Y.,Li, G.,Chen, A.,Zhou, Q.,Wang, M.W. Molecular architecture responsible for specific inhibition of oncogenic PI3K alpha mutants by RLY-2608 and STX-478. Acta Pharm Sin B, 16:5884-5900, 2026 Cited by PubMed Abstract: Hotspot mutations in phosphoinositide 3-kinase alpha (PI3K), such as H1047R, E542K, and E545K, drive tumorigenesis across multiple cancer types. Orthosteric PI3K inhibitors are effective but have toxicity against wild-type PI3K, the emergence of resistance, and a narrow therapeutic index. Allosteric inhibitors such as RLY-2608 and STX-478 offer a promising path toward mutant-specific suppression, yet the structural basis for their selectivity and mechanisms of action remain elusive. Here, we report high-resolution cryogenic electron microscopy structures of RLY-2608- and STX-478-bound H1047R, E542K, and E545K, revealing a shared cryptic allosteric pocket, accessible only through a major conformational rearrangement of the activation loop that is stabilized in oncogenic mutants. While both inhibitors occupy this pocket, they have distinct interaction networks and propagate divergent allosteric activities: RLY-2608 induces large-scale remodeling of catalytic and membrane-interacting elements, whereas STX-478 reinforces autoinhibitory interfaces between p110 and p85 subunits. Comparative analysis provides structural insights into their differentiated potency and selectivity. PubMed: 42764855DOI: 10.1016/j.apsb.2026.07.003 PDB entries with the same primary citation |
| Experimental method | ELECTRON MICROSCOPY (2.89 Å) |
Structure validation
Download full validation report






